Centene Corporation
CNCHealthcareNASDAQHealthcare Plans · Last scanned Oct 26, 2026
Scan Results
Daily timeframePart of the healthcare sector, Centene Corporation (CNC) is listed under Healthcare Plans. The company carries a $34.66B market cap, placing it firmly in the large-cap category. It operates through four segments: Medicaid, Medicare, Commercial, and Other.
Market Cap
$34.66B
Beta
1.13
P/E (TTM)
—
P/E (Fwd)
13.12
EPS (TTM)
$-10.44
EPS (Fwd)
$5.35
ROE
-20.4%
ROA
2.5%
Cash
$27.06B
Total Debt
$16.10B
Free CF
$9.64B
52W Change
111.7%
Annual Financials
Cash vs Debt
Where CNC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, CNC finished 17.98% above its 150-day moving average ($58.17) and 26.44% above its 200-day moving average ($54.28). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CNC overbought or oversold?
At the October 20, 2026 close, CNC's RSI(14) was 73.7, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $27.06B in cash comfortably exceeding the $16.10B debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $9.64B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -20.4%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $144.55B (2022) to $194.78B (2025), reflecting a 35% increase over the period.
Investors considering Centene Corporation should weigh the typical risks associated with CNC's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing CNC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.